Abstract:
EUS-FNA for diagnosis of pancreatic cancer may be inconclusive in up to 20% of cases. Adjunctive techniques to improve diagnostic yield of EUS-FNA are needed. In addition, defining signaling pathways would have widespread implications in providing targeted therapy to improve overall survival.
Citation:
Wani, S., Wang-Gillam, A., Early, D. S., Kim, P., Mullady, D., Murad, F., ... & Hollander, T. G. (2012). Comparison of Phosphorylation Signatures in Patients With Suspected Pancreatic Cancer Undergoing Endoscopic Ultrasound-Fine Needle (EUS-FNA) With and Without Malignant Cytology: A Pilot Study. Gastrointestinal Endoscopy, 75(4), AB189-AB190.